Core Scientific Statistics
Total Valuation
Core Scientific has a market cap or net worth of $6.38 billion. The enterprise value is $6.94 billion.
Important Dates
The last earnings date was Friday, October 24, 2025, after market close.
| Earnings Date | Oct 24, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Core Scientific has 310.06 million shares outstanding. The number of shares has increased by 6.29% in one year.
| Current Share Class | 310.06M |
| Shares Outstanding | 310.06M |
| Shares Change (YoY) | +6.29% |
| Shares Change (QoQ) | +0.18% |
| Owned by Insiders (%) | 1.44% |
| Owned by Institutions (%) | 80.26% |
| Float | 255.30M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 490.93 |
| PS Ratio | 18.28 |
| Forward PS | 7.89 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 44.82 |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 20.76 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.58
| Current Ratio | 1.58 |
| Quick Ratio | 1.22 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -10.14 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -6.06% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | -9.60% |
| Revenue Per Employee | $1.03M |
| Profits Per Employee | -$2.01M |
| Employee Count | 325 |
| Asset Turnover | 0.21 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Core Scientific has paid $863,000 in taxes.
| Income Tax | 863,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +44.61% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | +44.61% |
| 50-Day Moving Average | 16.77 |
| 200-Day Moving Average | 12.67 |
| Relative Strength Index (RSI) | 66.90 |
| Average Volume (20 Days) | 17,610,865 |
Short Selling Information
The latest short interest is 58.70 million, so 18.93% of the outstanding shares have been sold short.
| Short Interest | 58.70M |
| Short Previous Month | 62.39M |
| Short % of Shares Out | 18.93% |
| Short % of Float | 22.99% |
| Short Ratio (days to cover) | 4.06 |
Income Statement
In the last 12 months, Core Scientific had revenue of $334.18 million and -$654.25 million in losses. Loss per share was -$2.15.
| Revenue | 334.18M |
| Gross Profit | 34.14M |
| Operating Income | -156.08M |
| Pretax Income | -767.44M |
| Net Income | -654.25M |
| EBITDA | -75.23M |
| EBIT | -156.08M |
| Loss Per Share | -$2.15 |
Full Income StatementBalance Sheet
The company has $453.44 million in cash and $1.16 billion in debt, giving a net cash position of -$708.41 million or -$2.28 per share.
| Cash & Cash Equivalents | 453.44M |
| Total Debt | 1.16B |
| Net Cash | -708.41M |
| Net Cash Per Share | -$2.28 |
| Equity (Book Value) | -1.13B |
| Book Value Per Share | -3.66 |
| Working Capital | 391.17M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $138.99 million and capital expenditures -$482.95 million, giving a free cash flow of -$343.97 million.
| Operating Cash Flow | 138.99M |
| Capital Expenditures | -482.95M |
| Free Cash Flow | -343.97M |
| FCF Per Share | -$1.11 |
Full Cash Flow StatementMargins
Gross margin is 10.21%, with operating and profit margins of -46.71% and -229.91%.
| Gross Margin | 10.21% |
| Operating Margin | -46.71% |
| Pretax Margin | -229.65% |
| Profit Margin | -229.91% |
| EBITDA Margin | -22.51% |
| EBIT Margin | -46.71% |
| FCF Margin | n/a |
Dividends & Yields
Core Scientific does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -6.29% |
| Shareholder Yield | -6.29% |
| Earnings Yield | -10.50% |
| FCF Yield | -5.52% |
Analyst Forecast
The average price target for Core Scientific is $20.65, which is 0.39% higher than the current price. The consensus rating is "Buy".
| Price Target | $20.65 |
| Price Target Difference | 0.39% |
| Analyst Consensus | Buy |
| Analyst Count | 16 |
| Revenue Growth Forecast (5Y) | 33.83% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Core Scientific has an Altman Z-Score of -1.81 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -1.81 |
| Piotroski F-Score | 2 |
